Week 7- DM/ Thyroid Flashcards
What drug is in the biguanide class
metformin (glucophage)
what MoA is metformin
Decrease hepatic glucose production by decreasing gluconeogenesis
Causes an increase in peripheral glucose uptake + utilization (sensitivity)
(Reduces glucose uptake in GI tract)
Does not stimulate insulin release
what are the common uses for metformin
first line DM medication, initial monotherapy for adults/kids
black box warning of metformin
BOX WARNING: Rare but life-threatening lactic acidosis, hypothermia, hypotension, bradycardia death (50% fatality)
side effects of metformin
gas, diarrhea, weight loss, DOES NOT DIRECTLY C/ HYPOGLYCEMIA.. but it can still happen
contraindications of metformin
advanced renal disease, metabolic acidosis, monitor renal function
drug interactions of metformin
avoid iodine-based contrast (hold 48 hrs before/after imaging), watch drugs that use renal excretion too
what drugs are in the DPP-4 inhibitor class
linagliptin, saxagliptin, sitagliptin
MoA of gliptans
Acts on incretin system- stimulate insulin secretion from pancreatic beta cells
Slow gastric emptying by prolonging action of GLP-1 hormones
common uses of gliptins
DM-2
OK monotherapy—
Typically adjunct
Overweight & DM-2
side effects of gliptins
Arthralgia
Pancreatitis
Skin autoimmune issues
Rhabdo
Heart failure
drug interactions of gliptins
ACEI, DM drugs, Quinilones, Protease inhibitors: Higher risk hypoglycemia
Dig
GLP-1 receptor agonist drugs
dulaglutitide, exenatide, liraglutide
MoA of GLP-1 “glutides”
Acts on incretin system- stimulate insulin secretion from pancreatic beta cells and decrease glucagon release from alpha cells
(increases insulin secretion, lowers glucose levels, delays gastric emptying, induces weight loss)
GLP-1 Receptor Agonists
Combo w/ other meds for poorly controlled type 2 DM
& Obesity + CVD
NOT FOR DM-1
CI for all GLP 1 Receptor Agonists
GI disease (UC, crohn’s, gastroparesis, pancreatitis
also not recommends for people with renal impairment
side effects of GLP-1 receptor agonists
GI distubrances, pancreatic duct metaplasia, pancreatitis, thyroid tumors
black box warning GLP 1 Receptor
Agonists
thyroid C-Cell tumors and hyperplasia BOX WARNING
which GLP 1 agonists has the most nausea
exenatide
Dulaglutide can increase or decrease CV events
Decrease CV events
DDI of GLP 1
Most drug interactions tied to delayed gastric emptying & dual therapy hypoglycemia
ASA, salicylates, fibrates, MAOIs, sulfonamides, ARBs and ACEIs, beta blockers, contraceptives, Dig
which GLP 1 has the highest propensity for increased INR with warfarin
exenatide
which drugs are SGLT2 inhibitors
canaglifozin, dapagliflozin, empaglifozin “flozins”
what is the mechanism of action of flozins/ SGLT2 inhibitors
Inhibits SGLT2: blocks reabsorption of glucose in the kidneys & promotes excretion of glucose
No effect on natural insulin secretion
monotherapy of flozins
DM-2 (can be monotherapy)
Can be renal protective in pts w/ new dx DM-2
Reduce HF Hospitalizations
side effects of flozins
Hypotension (from volume loss)
Most common: Genital fungal infections, UTIs and increased urination
Increase LDL
side effects of canaglifozin
monitor for new pain, sores, or ulcers in lower limbs (D/C)
flozin contraindications
Contraindicated in renal impairment, ESRD
what drugs are in the sulfonylurea gland
glimepiride, glipizide, glyburdie
sulfonylureas mechanism of action
Stimulate insulin release from panc beta cells, suppression of glucose from liver
Oral Hypoglycemic
(Must have some endogenous insulin secretion)